Chronic Kidney Disease: Early Signs and Why Screening Matters
Advertisement
Chronic kidney disease (CKD) is long-term damage to the kidneys, reduced filtering ability, or both, commonly defined by guidelines as lasting more than three months, with implications for health. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, part of the National Institutes of Health), damaged kidneys may not remove waste and extra fluid from the blood as they should. The NHS describes CKD as a long-term condition in which the kidneys do not work as well as they should. The World Health Organization (WHO) and KDIGO similarly define CKD as abnormalities of kidney structure or function present for more than three months.
Early CKD is often silent. People may feel well for a long time and only learn they have kidney disease through blood and urine tests done for another reason or because they are at higher risk. The Centers for Disease Control and Prevention (CDC) notes that people with CKD may not feel ill, and that blood and urine tests are the only way to know for sure. Feeling fine does not mean the kidneys are fine.
Finding CKD earlier matters because lifestyle measures, blood pressure and glucose control, and clinician-prescribed medicines may slow progression and reduce heart risk. CKD also raises the chance of heart attack and stroke even when kidney disease is mild. Advanced disease can progress toward kidney failure requiring dialysis or transplant, but the NHS notes that kidney failure is uncommon, and around 2 in 100 people with CKD progress to that point. Many people live with CKD for a long time with monitoring and treatment.
Key Takeaways
- Early CKD is often silent; feeling well does not rule out kidney disease. Blood eGFR and urine albumin tests are how CKD is usually found.
- Risk-based testing focuses on people with diabetes, high blood pressure, cardiovascular disease, prior acute kidney injury, family history of kidney disease, and other clinician-identified conditions; NICE does not use age, gender, ethnicity, or obesity alone as testing reasons.
- Urine albumin thresholds use different unit systems (NIDDK, CDC and NKF often use mg/g; UK NICE/NHS mg/mmol; WHO equates ACR >3 mg/mmol ≈ 30 mg/g). Never mix units without labels, and clinicians interpret trends over time.
What Chronic Kidney Disease Is, and Why It Can Stay Silent
A long-term problem, not a one-day injury
CKD develops slowly in most people. NIDDK explains that kidneys can become damaged or structurally impaired so they do not filter blood as they should; waste and extra fluid can build up. The National Kidney Foundation (NKF) states that CKD means kidney damage or reduced function lasting at least three months. NICE guideline NG203 and KDIGO 2024 define CKD as abnormalities of kidney function or structure present for more than three months with health implications, including markers of kidney damage and/or reduced glomerular filtration rate (GFR).
This is different from acute kidney injury (AKI), a sudden drop in kidney function that WHO distinguishes from chronic disease. After AKI, clinicians may wait before diagnosing CKD; KDIGO notes waiting about three months after AKI before calling the problem chronic. Prior AKI is itself a reason some guidelines recommend later kidney checks.
How common is undiagnosed disease?
Prevalence figures are jurisdiction-specific. The CDC states that more than 1 in 7 U.S. adults have CKD, and as many as 9 in 10 do not know they have it. NIDDK cites more than 35 million U.S. adults, also described as more than 1 in 7. These numbers describe the United States, not the rest of the world. WHO emphasises that CKD progresses gradually, is frequently irreversible once advanced, and is often asymptomatic until late stages.
What "no cure" does and does not mean
The NHS states there is no cure for CKD, but treatments can slow worsening. NIDDK notes that advanced, long-lasting CKD typically cannot be reversed, while earlier detection allows changes that help protect remaining kidney function. "Cannot reverse all damage" is not the same as "nothing can be done." Treatment aims to slow progression, treat causes and reduce cardiovascular risk.
Early Signs and Later Symptoms (and Why Feeling Fine Is Not Enough)
Early disease is usually silent
Early CKD usually has no symptoms. Diabetes-related kidney disease, the ADA notes, can produce no symptoms until almost all function is gone, and when symptoms appear they are not specific. The NKF stresses that symptoms alone cannot tell someone whether they have CKD. Testing is required.
Features that may appear later
When symptoms do appear, often later or when there is much protein in the urine, common features include:
- Tiredness or reduced energy
- Swelling (oedema) of ankles, feet, or hands; less often face or limbs more broadly
- Shortness of breath
- Nausea, poor appetite, or unintentional weight loss
- Changes in urination: peeing more often (especially at night) or less often
- Foamy urine
- Itchy or dry skin
- Muscle cramps
- Trouble concentrating or sleeping
- Blood in the urine (needs clinician evaluation; NHS)
- In men, erectile dysfunction appears on the NHS later-symptom list
NIDDK also lists numbness, darkened skin, chest pain, and worsening oedema among more advanced features. WHO lists fatigue, breathlessness, generalised itch, leg swelling, muscle cramps, and nausea or vomiting among advanced symptoms.
Why this list is not a diagnosis
Many of these symptoms overlap with other conditions. Persistent or worrying symptoms warrant seeing a clinician; they do not replace blood and urine testing for kidney disease. Correcting the myth "I feel fine, so my kidneys are fine" is one of the main reasons screening of higher-risk people matters.
Who Should Ask About Screening, and Why It Matters
Because early CKD is often silent, major public bodies focus on risk-based testing (case-finding), not population screening of every asymptomatic adult without risk factors.
Ask a clinician whether kidney checks make sense if any of the following apply:
- Diabetes: leading driver of kidney damage across NIDDK, CDC, NHS, NICE, WHO, NKF, and ADA. People with diabetes are often advised to have kidney checks regularly (NIDDK: every year if you have diabetes).
- High blood pressure (hypertension)
- Cardiovascular / heart disease: CKD and heart disease travel together
- Prior acute kidney injury
- Family history of kidney disease, kidney failure, or hereditary kidney disease
- Other kidney-related conditions: structural renal tract disease, recurrent stones, prostatic hypertrophy, multisystem disease with potential kidney involvement (for example lupus), gout, unexplained protein or blood in urine, and long-term medicines that can affect kidneys (examples on NHS pages include lithium, omeprazole, and NSAIDs)
How jurisdictions differ on age, ethnicity, and obesity
NICE (UK) offers estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (ACR) testing to adults with risk factors such as diabetes, high blood pressure, cardiovascular disease or a previous acute kidney injury and explicitly says do not use age, gender, ethnicity, or obesity alone, without metabolic syndrome, diabetes, or hypertension, as reasons to test. NKF lists obesity and age over 60 among risk factors. NHS notes a higher likelihood of CKD in people of Black or south Asian origin; NIDDK notes higher rates of advanced kidney disease in some U.S. racial and ethnic groups, linked in part to rates of diabetes and high blood pressure. These are epidemiological observations, not a claim that biology alone determines who should be tested.
Advertisement
Finding CKD early allows lifestyle measures, blood pressure and glucose control, and medicines that may slow progression and lower heart risk. Prefer asking a clinician whether testing is appropriate for your situation rather than using a single universal checklist.
The Two Common Tests: eGFR (Blood) and Urine Albumin
Blood creatinine and estimated GFR
Clinicians typically use a blood creatinine result to calculate estimated glomerular filtration rate (eGFR), a measure of how well the kidneys filter. NIDDK describes the GFR blood test as one of the two cornerstone checks. The NHS notes that healthy kidneys often filter more than about 90 ml/min (as expressed on its diagnosis page), and that lower values may indicate CKD when interpreted with clinical context. Imaging or kidney biopsy is sometimes used when clinicians need more information (NHS, CDC).
Urine albumin (ACR / UACR)
The second cornerstone is urine albumin, often reported as the urine albumin-to-creatinine ratio (ACR, UACR, or uACR). Albumin leak into the urine can be an early marker of kidney damage even when eGFR is still relatively preserved. KDIGO emphasises classifying CKD by cause, GFR category (commonly discussed as G1-G5), and albuminuria category (A1-A3).
Why both tests matter together
NKF states that both eGFR and urine albumin testing are needed. An eGFR under 60 and/or a uACR over 30 (in U.S. mg/g units) lasting three months or more may be a sign of CKD. WHO describes CKD when two eGFR values below 60 at least 90 days apart are present, and/or when persistent albuminuria is present. NICE advises confirming a reduced eGFR that has not been tested before with a repeat within about two weeks when appropriate, and confirming clinically important proteinuria over time.
Understanding Rough Result Ranges: Without Self-Diagnosing
Muscle mass, pregnancy, acute illness, and other factors can affect eGFR interpretation (NICE). Clinicians interpret trends over time, usually looking for persistence over months.
eGFR bands
- Around ≥60: NIDDK discusses GFR of 60 or higher as closer to the normal range (and advises asking when to recheck). Values can still accompany kidney damage if urine albumin is abnormal.
- Below 60: NIDDK, CDC, NKF, NICE, WHO, and KDIGO discuss GFR below 60 as a threshold that may indicate CKD when persistent (often confirmed over ≥3 months / ≥90 days).
- Very low (around ≤15): NIDDK and CDC discuss very low GFR as indicating kidney failure or failing kidneys, when dialysis or transplant is often discussed.
NHS patient pages also describe eGFR stages labelled G1-G5; those full tables are for clinician-supported discussion, not self-assignment from a single lab printout.
Urine albumin: unit systems differ by country
Never treat the number "30" as interchangeable across unit systems without labelling.
- U.S. NIDDK, CDC and NKF often use mg/g. NIDDK: UACR ≤30 mg/g is discussed as normal range; above 30 mg/g may mean kidney disease and may be repeated to confirm. CDC: an albumin result of 30 or above may mean kidney disease (may repeat).
- UK NICE / NHS use mg/mmol, commonly grouped as A1 <3, A2 3-30, and A3 >30 mg/mmol. NICE treats ACR of 3 mg/mmol or higher as clinically important proteinuria (with confirmation rules on subsequent samples).
- WHO equates persistent albuminuria as ACR >3 mg/mmol (about 30 mg/g).
NICE and KDIGO use ACR categories A1-A3. Older ADA materials may still say microalbuminuria or macroalbuminuria for overlapping ideas.
Confirming chronicity
A single abnormal result is not the whole story. Repeat testing over time is used to confirm a result (often three months, or 90 days or more, for eGFR thresholds). Only a clinician should diagnose CKD.
When to See a Doctor, and When a Kidney Specialist May Be Involved
See a primary clinician for persistent or worrying symptoms that could be kidney-related, or if you have risk factors and have not been tested. NIDDK notes that a primary clinician may refer to a nephrologist when disease is complicated, rapidly worsening, or advanced.
Specialist referral is not a patient self-triage checklist. NICE NG203 lists situations in which clinicians may refer adults (wishes and comorbidities considered), including examples such as:
- High predicted five-year risk of needing renal replacement therapy on a validated kidney failure risk equation (NICE cites a threshold above 5% on the four-variable KFRE)
- Very high albuminuria (NICE cites ACR ≥70 mg/mmol unless known diabetes already appropriately treated; or ACR above 30 mg/mmol with haematuria)
- Sustained rapid eGFR decline (NICE cites category change with ≥25% decrease within 12 months, or sustained decrease ≥15 ml/min/1.73 m² per year)
- Hypertension poorly controlled despite multiple antihypertensives (NICE cites four or more)
- Known or suspected rare or genetic CKD, or suspected renal artery stenosis
U.S. readers should not assume UK numeric thresholds automatically apply; clinicians use risk, albuminuria, trajectory, blood pressure control, and suspected rare causes when deciding about nephrology input.
A Cochrane review of observational studies found that earlier nephrology referral, compared with late referral near the start of dialysis, was associated with lower mortality and better preparation for dialysis. There were no randomised trials in that review; definitions of "early" versus "late" varied. This supports thoughtful specialist involvement when disease is progressing or complex; it does not mean that every person with early-stage CKD needs a nephrologist.
When care plans feel unsettled or options are unclear, some people ask for a second opinion.
Protecting Your Kidneys: Lifestyle and Controlling Blood Pressure and Diabetes
Control the main drivers
Preventing or managing diabetes and high blood pressure, and supporting heart health, are central to protecting kidneys.
Advertisement
Blood pressure targets
Targets vary between organisations and with clinical context:
- CDC and NIDDK often discuss keeping blood pressure below 140/90 mm Hg, or a target the clinician sets.
- NHS CKD treatment information commonly gives aims as usually below 140/90, or below 130/80 if the person has diabetes.
- NICE uses clinic targets that can vary with albuminuria strata. These are clinician-applied, not patient self-targets.
Ask what target applies in your situation.
Everyday lifestyle steps
Common advice includes heart-healthy eating and individualised nutrition advice; limiting salt/sodium (NIDDK discusses less than about 2300 mg sodium per day; NHS discusses less than 6 g salt per day); physical activity (NIDDK often cites about 30 minutes most days; NHS cites at least 150 minutes per week); healthy weight if overweight; stopping smoking; limiting alcohol as advised; sleep and stress care; and caution with regular OTC NSAID painkillers (ibuprofen, naproxen, and similar) unless a clinician or pharmacist advises they are appropriate.
Medicines that may protect kidneys: clinician decides
Some blood pressure medicines in the ACE inhibitor or ARB classes, and other clinician-prescribed agents (NHS patient pages also mention SGLT2 inhibitors and statins in CKD care), may help protect kidneys or lower cardiovascular risk in selected people. Whether any medicine is suitable, and how it is monitored, is a clinician decision.
Living With CKD: Monitoring, Medicines and Heart Health
Many people live with CKD for a long time
The NHS notes that many people live long lives with CKD; damage already done may not fully reverse, but not everyone progresses to kidney failure. Regular reviews, taking prescribed medicines, checking over-the-counter products with a pharmacist or doctor, healthy diet, activity, and stopping smoking are recurring themes. NHS also discusses vaccinations such as annual flu vaccine and pneumococcal vaccine for people with CKD. Pathways are local.
Monitoring and heart health
NIDDK centres management on blood pressure, glucose, monitoring kidney tests, medicines, dietitian input when needed, activity, weight, sleep, stopping smoking, and stress. Goals often include keeping eGFR as stable as possible and urine albumin the same or lower over time. Even mild CKD raises cardiovascular risk (NHS, NKF, CDC, WHO). Kidney care and heart-risk care travel together.
Advanced disease
When kidneys fail, options include dialysis, transplant, or conservative supportive care (WHO, NHS). Those are separate decisions beyond early-detection education.
Myths and Uncertainties
"I feel fine, so my kidneys are fine" / "Symptoms alone diagnose CKD"
Early CKD is often asymptomatic; blood and urine tests may be the only way to know. Symptom lists overlap other illnesses and do not replace testing.
"Everyone with CKD ends up on dialysis" / "No cure means nothing helps"
NHS states that around 2 in 100 people with CKD progress to kidney failure. Many live with stable or slowly changing disease. "No cure" means established damage may not reverse; care still aims to slow progression, treat causes and cut heart risk.
Mixing albumin lab units / one blood pressure target for everyone
U.S. reports often use mg/g; UK reports often use mg/mmol. WHO equates roughly >3 mg/mmol ≈ 30 mg/g. Mixing those numbers without labels leads to false reassurance or false alarm. Blood pressure targets vary between organisations and with your situation. Ask what applies to you.
Age, ethnicity, or obesity alone as automatic screening rules
NKF discusses obesity and older age among risk factors; NICE says not to use age, gender, ethnicity, or obesity alone as testing indications. Screening decisions remain clinician-guided.
Conclusion
Chronic kidney disease is often silent early and closely tied to diabetes, high blood pressure, and heart health. Risk-based blood (eGFR) and urine albumin testing, not symptoms alone, is how CKD is usually found. Early detection supports lifestyle change, risk-factor control, and clinician-prescribed treatments that may slow progression and protect the heart. Lab ranges help only when units are labelled and trends are interpreted by a clinician. Ask about testing if you have diabetes, hypertension, cardiovascular disease, prior AKI, family history of kidney disease, or other conditions your clinician considers relevant, and do not assume that feeling well rules out kidney disease.
Medical Disclaimer
Content on MED.COM is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with questions about a medical condition. Never disregard professional medical advice or delay seeking it because of something read on this site. If you think you may have a medical emergency, contact local emergency services immediately.
Sources & References
- 1.What Is Chronic Kidney Disease in Adults?
National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) • Feb 1, 2025
- 2.Chronic Kidney Disease Tests & Diagnosis
National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) • Oct 1, 2016
- 3.Chronic kidney disease - Overview
NHS • Mar 22, 2023
- 4.Chronic kidney disease - Diagnosis
NHS • Mar 22, 2023
- 5.Chronic Kidney Disease Basics
Centers for Disease Control and Prevention • May 15, 2024
- 6.Testing for Chronic Kidney Disease
Centers for Disease Control and Prevention • May 15, 2024
- 7.Chronic kidney disease: assessment and management - Recommendations (NG203)
NICE • Nov 24, 2021
- 8.Chronic Kidney Disease (CKD)
National Kidney Foundation • Aug 24, 2026
- 9.CKD Evaluation and Management - KDIGO 2024 guideline hub
KDIGO • Mar 1, 2024
- 10.Kidney disease - Fact sheet
World Health Organization • Jan 1, 2025
- 11.Early referral to a specialist doctor for people with kidney disease
Cochrane • Jun 18, 2014
- 12.Chronic Kidney Disease (Nephropathy)
American Diabetes Association
Focus Areas
Stay informed with the latest medical insights from MED.COM
Advertisement
Related Articles
Nephrology & Kidney Health
High Blood Pressure and Kidney Disease: How Each Can Harm the Other
Nephrology & Kidney Health
Acute Kidney Injury: Causes, Warning Signs, and How It Differs From Chronic Kidney Disease
Nephrology & Kidney Health
Kidney Infection: Symptoms, Same-Day Warning Signs, and Who Is at Higher Risk
Nephrology & Kidney Health
Kidney Stones: Symptoms, Causes, and When to Seek Care
Infectious Diseases
Measles Symptoms: Early Signs, the Rash and When to Get Help
Cardiology & Heart Health
